Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof

A fusion protein, mammalian technology, applied in the field of fusion proteins, can solve the problems of low expression of fusion proteins, difficult to scale industrial production, and amplification, and achieve the effects of less adverse reactions and good immune effects.

Active Publication Date: 2007-02-28
BEIJING SUNBIO BIOTECH
View PDF4 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] However, the expression level of fusion proteins formed by full-length Hsp70 and tumor antigen peptides or pathogen antigens is very low, and it is difficult to scale up industrial production

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof
  • Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof
  • Fusion albumen containing HSP70 ATPase structure field and mammal p53 albumen and application thereof

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0030] Example 1. Construction and expression of genes encoding recombinant human HSP70ATPase domain and HPV E7 fusion protein (AE7)

[0031] The E7 and E6 proteins of human papillomavirus (HPV) play an important role in the tumorigenesis of HPV-infected patients (Fehrmann and Laimins, 2003). Therefore, the E7 and E6 proteins on the cell surface of HPV-infected patients can be used as tumor antigens. Recognized by T cells. The fusion protein composed of the ATPase domain of Hsp70 and E7 / E6 can enhance the human body's immune response to HPV virus and cervical cancer caused by it. We call the fusion protein of Hsp70 ATPase domain and E7 AE7, and call the fusion protein of Hsp70 ATPase domain and E6 AE6.

[0032] The human Hsp70 ATPase domain gene (amino acid residues 1-386) was obtained from the full-length human Hsp70 gene by PCR. The HPV virus type 16 E7 gene was obtained by PCR from the virus genome. The PCR product of Hsp70ATPase domain was digested with restriction enzymes Nde...

Embodiment 2

[0038] Example 2. Construction and expression of genes encoding recombinant human HSP70ATPase domain and HPV E6 fusion protein (AE6)

[0039] The HPV virus type 16 E6 gene was obtained by PCR from the virus genome. The PCR product was digested with restriction enzymes BamH I and Xho I and connected to S28bA, named S28bAE6. The AE6 nucleic acid sequence was confirmed by sequencing.

[0040] The S28bAE6 plasmid was transformed into E.coli BL21(DE3) strain for protein expression. The expression method of AE6 protein is the same as that of AE7. The renaturation and purification of AE6 protein is similar to that of AE7. The ATPase activity of AE6 is detected by the malachite green method. The results show that recombinant AE6 has all the functions of hydrolyzing ATP.

Embodiment 3

[0041] Example 3. Construction and expression of genes encoding recombinant human HSP70ATPase domain and human D53 fusion protein (hAP53)

[0042] The human p53 gene was obtained by PCR using a human liver cDNA library as a template. The PCR product of the human p53 gene was digested with restriction enzymes and then ligated to S28bA, named S28bhAP53. The nucleic acid sequence of the target gene was confirmed by DNA sequencing.

[0043] The protein expression, renaturation and purification methods of hAP53 are similar to those of AE7. The ATPase activity is detected by the malachite green method. The results show that the recombinant hAP53 has all the functions of hydrolyzing ATP.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a framework area including human HSP70 ATPase and human papillomavirus E7, E6 protein or merge protein of mammalian p53 protein. The invention also discloses a pharmaceutical compound of merge protein, gene of encoding merge protein, the expressive carrier of merge protein and the usage of preparing medicine to treat or avoid tumor as human papillomavirus or tumor related to p53 protein overdose express.

Description

Technical field [0001] The invention relates to a fusion protein comprising a heat shock protein adenosine triphosphate (ATPase) domain and an antigen peptide, more specifically, the invention relates to a fusion protein comprising a human HSP70 ATPase domain and a mammalian p53 protein. The present invention also relates to a pharmaceutical composition comprising the above-mentioned fusion protein, a gene encoding the above-mentioned fusion protein, an expression vector comprising the gene, and use thereof in the preparation of a medicine for treating or preventing tumors related to overexpression of p53 protein. Background technique [0002] It was discovered a long time ago that heat shock protein (Hsp) can promote the correct folding of protein molecules. Recently, it has been discovered that Hsp70, Hsp90, and Grp94 (also called gp96) can submit tumor antigen peptides to the MHC molecules of antigen presenting cells (antigen presenting cells, APCs) and be recognized by T cell...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K19/00A61K38/16A61K38/17A61P35/00A61P1/16C12N15/62C12N15/63A61K48/00
Inventor 朱冰
Owner BEIJING SUNBIO BIOTECH
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products